October ___, 2024 Dear Pierre Sayad (“Executive”):Employment Agreement • October 30th, 2024 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledOctober 30th, 2024 Company Industry JurisdictionOn behalf of the Board of Directors of Fennec Pharmaceuticals, Inc. (“Fennec” or the “Company”), I am pleased to make you an executable offer to join the Company as its Chief Medical Officer. The purpose of this agreement is to clarify the terms of Executive’s “at will” employment with the Company, including Executive’s compensation level and benefit entitlements.
October ___, 2024 Dear Christiana Cioffi (“Executive”):Employment Agreement • October 30th, 2024 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledOctober 30th, 2024 Company Industry JurisdictionOn behalf of the Board of Directors of Fennec Pharmaceuticals, Inc. (“Fennec” or the “Company”), I am pleased to make you an executable offer to join the Company as its Chief Strategy Officer. The purpose of this agreement is to clarify the terms of Executive’s “at will” employment with the Company, including Executive’s compensation level and benefit entitlements.
October ___, 2024 Dear Terry Evans (“Executive”):Employment Agreement • October 30th, 2024 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledOctober 30th, 2024 Company Industry JurisdictionOn behalf of the Board of Directors of Fennec Pharmaceuticals, Inc. (“Fennec” or the “Company”), I am pleased to make you an executable offer to join the Company as its Chief Commercial Officer. The purpose of this agreement is to clarify the terms of Executive’s “at will” employment with the Company, including Executive’s compensation level and benefit entitlements.